Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 10Terminated 6Withdrawn 3Recruiting 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1CNS 1Breast 1

Conditions

Laryngeal Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Fluorescein × Clear all
NCT02540135 2018-07-20

Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma

University of Colorado, Denver

Phase NA Withdrawn
CNS

Astrocytoma, Glioblastoma, Glioma

NCT02628496 2016-09-09

Confocal Laser Microlaryngoscopy (CLMx)

Washington University School of Medicine

Phase NA Withdrawn
Head & Neck

Laryngeal Neoplasms

NCT01614184 2013-07-10

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

University of Utah

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡